Some GLP-1 receptor agonists may hold promise as treatments for alcohol use disorder (AUD), a Swedish observational study ...

Depending on the medication, the effects can last for a minimum of 24 hours to a few weeks. Examples include dulaglutide, ...

The finding in the study is not the first of its kind. A 2022 study of 127 people found that GLP-1 drug exenatide reduced ...

Vivani Medical, Inc. (Nasdaq: VANI) ("Vivani" or the "Company"), a biopharmaceutical company developing miniaturized, ...

A clinical trial published in 2022 found that an older GLP-1 drug called exenatide reduced drinking, but only among those who ...

8 Other type 2 diabetes medications used to treat women with PCOS include exenatide, orlistat, and liraglutide. 1 Exenatide ...

1 A cohort of 227,886 individuals was followed from AUD diagnosis until death, emigration, or the study's end date, December ...

The blockbuster drugs Ozempic and Wegovy may help people cut back on drinking, new research published Wednesday in JAMA ...

Objective–To investigate the effect of treatment with the glucagon-like peptide 1 receptor agonist exenatide on weight loss and metabolic parameters in obese nondiabetic women. Research Design ...

However, the overall safety profile of taspoglutide was clearly worse than exenatide with respect to gastrointestinal tolerability, systemic allergic reactions, and injection-site reactions.

The warning affects all treatments containing GLP-1 receptor agonists, including semaglutide ( Ozempic, Wegovy, Rybelsus ), ...

Two-year data from a phase 3 trial of exenatide in Parkinson’s is due later this year and could help answer that question, said Prof Foltynie. Just as for previous schemes, metrics are being ...